Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

Hair follicle stem cells are better than dental pulp stem cells at becoming insulin-producing cells, useful for diabetes therapy.

Immune cells called Treg cells are essential for hair growth and regeneration.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Human hair matrix cells and dermal papilla fibroblasts can form early hair follicle structures but don't produce hair shafts yet.

MED1 is essential for normal hair growth and maintaining hair follicle stem cells.

Hair loss in males and females is influenced by immune cell interactions, with potential treatments identified.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

SH-MSCs can improve hair growth by balancing gene expressions in fluconazole-related hair loss.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Researchers successfully grew hair follicle stem cells from mice and humans, which could be useful for tissue engineering and regenerative medicine.